Covid-19 Impact on Global mRNA Treatment Market Size, Status and Forecast 2020-2026
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by mRNA Treatment Revenue
- 1.4 Covid-19 Implications on Market by Type
- 1.4.1 Global mRNA Treatment Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Vaccine
- 1.4.3 Drugs
- 1.5 Market by Application
- 1.5.1 Global mRNA Treatment Market Share by Application: 2020 VS 2026
- 1.5.2 Protein Diseases
- 1.5.3 Gene Dysfunction Diseases
- 1.5.4 Others
- 1.6 Coronavirus Disease 2019 (Covid-19): mRNA Treatment Industry Impact
- 1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.6.2 Covid-19 Impact: Commodity Prices Indices
- 1.6.3 Covid-19 Impact: Global Major Government Policy
- 1.7 Study Objectives
- 1.8 Years Considered
2 Global Growth Trends
- 2.1 Covid-19 Implications on Global mRNA Treatment Market Perspective (2015-2026)
- 2.2 Covid-19 Implications on Global mRNA Treatment Growth Trends by Regions
- 2.2.1 mRNA Treatment Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 mRNA Treatment Historic Market Share by Regions (2015-2020)
- 2.2.3 mRNA Treatment Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 mRNA Treatment Market Growth Strategy
- 2.3.6 Primary Interviews with Key mRNA Treatment Players (Opinion Leaders)
3 Covid-19 Implications on Competition Landscape by Key Players
- 3.1 Global Top mRNA Treatment Players by Market Size
- 3.1.1 Global Top mRNA Treatment Players by Revenue (2015-2020)
- 3.1.2 Global mRNA Treatment Revenue Market Share by Players (2015-2020)
- 3.1.3 Global mRNA Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global mRNA Treatment Market Concentration Ratio
- 3.2.1 Global mRNA Treatment Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by mRNA Treatment Revenue in 2019
- 3.3 mRNA Treatment Key Players Head office and Area Served
- 3.4 Key Players mRNA Treatment Product Solution and Service
- 3.5 Date of Enter into mRNA Treatment Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Implications on Market Size by Type (2015-2026)
- 4.1 Global mRNA Treatment Historic Market Size by Type (2015-2020)
- 4.2 Global mRNA Treatment Forecasted Market Size by Type (2021-2026)
5 Covid-19 Implications on Market Size by Application (2015-2026)
- 5.1 Global mRNA Treatment Market Size by Application (2015-2020)
- 5.2 Global mRNA Treatment Forecasted Market Size by Application (2021-2026)
6 North America Impact of COVID-19
- 6.1 North America mRNA Treatment Market Size (2015-2020)
- 6.2 mRNA Treatment Key Players in North America (2019-2020)
- 6.3 North America mRNA Treatment Market Size by Type (2015-2020)
- 6.4 North America mRNA Treatment Market Size by Application (2015-2020)
7 Europe Impact of COVID-19
- 7.1 Europe mRNA Treatment Market Size (2015-2020)
- 7.2 mRNA Treatment Key Players in Europe (2019-2020)
- 7.3 Europe mRNA Treatment Market Size by Type (2015-2020)
- 7.4 Europe mRNA Treatment Market Size by Application (2015-2020)
8 China Impact of COVID-19
- 8.1 China mRNA Treatment Market Size (2015-2020)
- 8.2 mRNA Treatment Key Players in China (2019-2020)
- 8.3 China mRNA Treatment Market Size by Type (2015-2020)
- 8.4 China mRNA Treatment Market Size by Application (2015-2020)
9 Japan Impact of COVID-19
- 9.1 Japan mRNA Treatment Market Size (2015-2020)
- 9.2 mRNA Treatment Key Players in Japan (2019-2020)
- 9.3 Japan mRNA Treatment Market Size by Type (2015-2020)
- 9.4 Japan mRNA Treatment Market Size by Application (2015-2020)
10 Southeast Asia Impact of COVID-19
- 10.1 Southeast Asia mRNA Treatment Market Size (2015-2020)
- 10.2 mRNA Treatment Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia mRNA Treatment Market Size by Type (2015-2020)
- 10.4 Southeast Asia mRNA Treatment Market Size by Application (2015-2020)
11 India Impact of COVID-19
- 11.1 India mRNA Treatment Market Size (2015-2020)
- 11.2 mRNA Treatment Key Players in India (2019-2020)
- 11.3 India mRNA Treatment Market Size by Type (2015-2020)
- 11.4 India mRNA Treatment Market Size by Application (2015-2020)
12 Central & South America Impact of COVID-19
- 12.1 Central & South America mRNA Treatment Market Size (2015-2020)
- 12.2 mRNA Treatment Key Players in Central & South America (2019-2020)
- 12.3 Central & South America mRNA Treatment Market Size by Type (2015-2020)
- 12.4 Central & South America mRNA Treatment Market Size by Application (2015-2020)
13Key Players Profiles
- 13.1 CureVac
- 13.1.1 CureVac Company Details
- 13.1.2 CureVac Business Overview and Its Total Revenue
- 13.1.3 CureVac mRNA Treatment Introduction
- 13.1.4 CureVac Revenue in mRNA Treatment Business (2015-2020))
- 13.1.5 CureVac Recent Development and Reaction to COVID-19
- 13.2 Moderna
- 13.2.1 Moderna Company Details
- 13.2.2 Moderna Business Overview and Its Total Revenue
- 13.2.3 Moderna mRNA Treatment Introduction
- 13.2.4 Moderna Revenue in mRNA Treatment Business (2015-2020)
- 13.2.5 Moderna Recent Development and Reaction to COVID-19
- 13.3 BioNTech (Pfizer)
- 13.3.1 BioNTech (Pfizer) Company Details
- 13.3.2 BioNTech (Pfizer) Business Overview and Its Total Revenue
- 13.3.3 BioNTech (Pfizer) mRNA Treatment Introduction
- 13.3.4 BioNTech (Pfizer) Revenue in mRNA Treatment Business (2015-2020)
- 13.3.5 BioNTech (Pfizer) Recent Development and Reaction to COVID-19
- 13.4 Sanofi (Translate Bio)
- 13.4.1 Sanofi (Translate Bio) Company Details
- 13.4.2 Sanofi (Translate Bio) Business Overview and Its Total Revenue
- 13.4.3 Sanofi (Translate Bio) mRNA Treatment Introduction
- 13.4.4 Sanofi (Translate Bio) Revenue in mRNA Treatment Business (2015-2020)
- 13.4.5 Sanofi (Translate Bio) Recent Development and Reaction to COVID-19
- 13.5 Ethris (AstraZeneca)
- 13.5.1 Ethris (AstraZeneca) Company Details
- 13.5.2 Ethris (AstraZeneca) Business Overview and Its Total Revenue
- 13.5.3 Ethris (AstraZeneca) mRNA Treatment Introduction
- 13.5.4 Ethris (AstraZeneca) Revenue in mRNA Treatment Business (2015-2020)
- 13.5.5 Ethris (AstraZeneca) Recent Development and Reaction to COVID-19
- 13.6 Kernal Biologics
- 13.6.1 Kernal Biologics Company Details
- 13.6.2 Kernal Biologics Business Overview and Its Total Revenue
- 13.6.3 Kernal Biologics mRNA Treatment Introduction
- 13.6.4 Kernal Biologics Revenue in mRNA Treatment Business (2015-2020)
- 13.6.5 Kernal Biologics Recent Development and Reaction to COVID-19
- 13.7 RaNA Therapeutics
- 13.7.1 RaNA Therapeutics Company Details
- 13.7.2 RaNA Therapeutics Business Overview and Its Total Revenue
- 13.7.3 RaNA Therapeutics mRNA Treatment Introduction
- 13.7.4 RaNA Therapeutics Revenue in mRNA Treatment Business (2015-2020)
- 13.7.5 RaNA Therapeutics Recent Development and Reaction to COVID-19
- 13.8 Silence Therapeutics
- 13.8.1 Silence Therapeutics Company Details
- 13.8.2 Silence Therapeutics Business Overview and Its Total Revenue
- 13.8.3 Silence Therapeutics mRNA Treatment Introduction
- 13.8.4 Silence Therapeutics Revenue in mRNA Treatment Business (2015-2020)
- 13.8.5 Silence Therapeutics Recent Development and Reaction to COVID-19
14Analyst's Viewpoints/Conclusions
15Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
mRNA Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global mRNA Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the mRNA Treatment market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the mRNA Treatment industry.
The key players covered in this study
CureVac
Moderna
BioNTech (Pfizer)
Sanofi (Translate Bio)
Ethris (AstraZeneca)
Kernal Biologics
RaNA Therapeutics
Silence Therapeutics
Market segment by Type, the product can be split into
Vaccine
Drugs
Market segment by Application, split into
Protein Diseases
Gene Dysfunction Diseases
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global mRNA Treatment status, future forecast, growth opportunity, key market and key players.
To present the mRNA Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of mRNA Treatment are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.